SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-027232
Filing Date
2021-05-18
Accepted
2021-05-17 17:45:23
Documents
56
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_soligenix.htm 10-Q 499492
2 CERTIFICATION f10q0321ex31-1_soligenix.htm EX-31.1 9033
3 CERTIFICATION f10q0321ex31-2_soligenix.htm EX-31.2 8872
4 CERTIFICATION f10q0321ex32-1_soligenix.htm EX-32.1 3087
5 CERTIFICATION f10q0321ex32-2_soligenix.htm EX-32.2 3026
  Complete submission text file 0001213900-21-027232.txt   3205752

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE sngx-20210331.xml EX-101.INS 390877
7 XBRL SCHEMA FILE sngx-20210331.xsd EX-101.SCH 51837
8 XBRL CALCULATION FILE sngx-20210331_cal.xml EX-101.CAL 41883
9 XBRL DEFINITION FILE sngx-20210331_def.xml EX-101.DEF 197499
10 XBRL LABEL FILE sngx-20210331_lab.xml EX-101.LAB 421588
11 XBRL PRESENTATION FILE sngx-20210331_pre.xml EX-101.PRE 214211
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14778 | Film No.: 21932830
SIC: 2834 Pharmaceutical Preparations